LexisNexis® Legal Newsroom
Mealey's Litigation Report: Intellectual Property -- Patentability Of Medical Treatment Claims Debated Before Supreme Court

WASHINGTON, D.C. - One year after vacating and remanding a Federal Circuit U.S. Court of Appeals determination that medical treatment protocol steps are patentable, the U.S. Supreme Court heard oral argument today in the same case ( Mayo Collaborative Services and Mayo Clinic Rochester v. Prometheus...

Fitch, Even, Tabin & Flannery: Mayo Case Could Clarify Patentability Standards for “Personalized Medicine”

On Wednesday, December 7, 2011, the U.S. Supreme Court heard oral arguments in a major patent case, Mayo Collaborative Services, v. Prometheus Laboratories . The decision in this case should clarify the metes and bounds of what qualifies as patentable subject matter under the patent laws. The Mayo case...

Ballard Spahr LLP: Justices Deny Patent Protection for Medical Process

By Mary Anthony Merchant , J. Gibson Lanier , and Scott D. Marty In one of the most anticipated IP cases on this year's docket, the U.S. Supreme Court on Tuesday held that a medical process for testing blood was not eligible for patent protection because the patent claims only recited laws of nature...

Brinks Hofer Gilson & Lione: Supreme Court Rules Certain Medical Method Patent Claims are Akin to "Laws of Nature" and Thus Not Patentable in Mayo Collaborative Services v. Prometheus Laboratories, Inc.

On March 20, 2012, the Supreme Court issued a highly anticipated decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc ., No. 10-1150 [ enhanced version available to lexis.com subscribers ]. In a unanimous decision, the Court held that Prometheus' method claims were not eligible...

Fitch, Even, Tabin & Flannery LLP: Supreme Court Holds Prometheus Patents Invalid

On March 20, 2012, in Mayo Collaborative Services v. Prometheus Laboratories, Inc. , the U.S. Supreme Court issued a landmark decision on patent eligibility under the patent statute, a decision that specifically addressed the "laws of nature" exclusion for patent eligibility. Unanimously reversing...

Sheppard Mullin Richter & Hampton LLP: Supreme Court Holds That a Law of Nature Applied Using Known and Obvious Steps Is Not Patent Eligible

By Kevin Capps On March 20, 2012, the Supreme Court issued its much-anticipated decision in Mayo Collaborative Services, DBA Mayo Medical Laboratories, et al. v. Prometheus Laboratories, Inc . [ enhanced version available to lexis.com subscribers ], with potentially far-reaching ramifications for pharmaceutical...

Fitch, Even, Tabin & Flannery LLP: Supreme Court Vacates and Remands Software Patent Case

The U.S. Supreme Court has granted certiorari in WildTangent, Inc. v. Ultramercial, LLC, et al . [ enhanced version available to lexis.com subscribers ], and has instructed the Court of Appeals for the Federal Circuit to revisit its WildTangent decision in light of the Court's holding in Mayo Collaborative...

Troutman Sanders LLP: Prometheus: Patent-Eligibility Revisited

[originally posted 4/2/2012] By Douglas "Doug" D. Salyers , James Moore Bollinger , Robert A. Angle , Daniel A. Ladow and George B. Snyder The Supreme Court's recent holding in Mayo Collaborative Services v. Prometheus Laboratories, Inc . [ enhanced version available to lexis.com subscribers...

New Examining Procedure Related to Mayo v. Prometheus

From the US. Patent and Trademark Office: I am pleased to report that Deputy Commissioner for Patent Examination Policy Drew Hirshfeld issued a memorandum to all patent examiners implementing a new procedure for examining process claims for subject matter eligibility in view of the Supreme Court decision...

Patents Post-Grant: USPTO Provides Feedback on Prometheus Issues

Examination Guidelines & Reexamination Determination Issued Last week, the USPTO issued examination guidelines in light of the ruling in Mayo v. Prometheus [ enhanced version available to lexis.com subscribers ] this past March . The guidelines are entitled "2012 Interim Procedure for Subject...